Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

63%

5 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

4(50.0%)

N/A

2(25.0%)

Phase 3

1(12.5%)

Phase 2

1(12.5%)

8Total

Phase 4(4)

N/A(2)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04646096Not ApplicableCompleted

Multicenter Study for Robotic Arm-assisted THA 4.0 System: Hip Spine Relationship

Role: lead

NCT06500364Phase 4Recruiting

Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study

Role: lead

NCT06462482Phase 4Not Yet Recruiting

Peri-Operative Testosterone Administration in Primary Hip Arthroscopy

Role: lead

NCT06608914Phase 4Not Yet Recruiting

Peri-Operative Testosterone Administration in Primary Total Hip Arthroplasty

Role: lead

NCT06750757Phase 4Not Yet Recruiting

Intraoperative Bone Marrow Aspirate Concentrate Injections: Evaluating Outcomes in a Randomized Controlled Trial

Role: lead

NCT04265222Not ApplicableActive Not Recruiting

Cam Decompression Utilizing the Stryker Hip-Check Software Platform

Role: lead

NCT05722301Phase 3Withdrawn

Does Testosterone Therapy Improve Patient-Reported Outcomes in Age-Related Testosterone Deficient Patients Undergoing Total Hip Replacement: A Randomized-Controlled Trial

Role: lead

NCT03001453Phase 2Completed

Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management

Role: lead

All 8 trials loaded